2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies. (15th January 2021)
- Record Type:
- Journal Article
- Title:
- 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies. (15th January 2021)
- Main Title:
- 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies
- Authors:
- Haroun, Michelyne
Tratrat, Christophe
Petrou, Anthi
Geronikaki, Athina
Ivanov, Marina
Ciric, Ana
Sokovic, Marina - Abstract:
- Graphical abstract: Abstract: The search for new antimicrobial agents is greater than ever due to the perpetual threat of multidrug resistance in known pathogens and the relentless emergence of new infections. In this manuscript, ten thiazole-based thiazolidinone hybrids bearing a 6-trifluoromethoxy substituent on the benzothiazole core were synthesized and evaluated against a panel of four bacterial strains Salmonella typhimurium, Staphylococcus aureus, Escherichia coli and Listeria monocytogenes and three resistant strains Pseudomonas aeruginosa, E. coli and MRSA. The evaluation of minimum bactericidal and minimum inhibitory concentrations was accomplished by microdilution assay. As reference compounds ampicillin and streptomycin were employed. All compounds displayed antibacterial efficiencies with MBCs/MICs at 0.25–1 mg/mL and 0.12–1 mg/mL respectively while ampicillin displayed MBCs/MICs at 0.15–0.3 mg/mL and at 0.1–0.2 mg/mL respectively. MICs/MBC of streptomycin varied from 0.05 to 0.15 mg/mL and from 0.1 to 0.3 mg/mL respectively. The best overall effect was observed for compound h4, while compound h1 exhibited the highest effective action against E. coli (MIC/MBC 0.12/0.25 mg/ml) among all tested compounds.
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 32(2021)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 32(2021)
- Issue Display:
- Volume 32, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 32
- Issue:
- 2021
- Issue Sort Value:
- 2021-0032-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01-15
- Subjects:
- Antibacterial -- Thiazolidinone -- Ampicillin -- Benzothiazole -- MurB
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2020.127718 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15406.xml